Drug profile · INN
chlorphenesin carbamate
MAOLATE
chlorphenesin carbamate (MAOLATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — chlorphenesin carbamate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
chlorphenesin carbamate (MAOLATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN chlorphenesin carbamate
Brand MAOLATE
Mechanism Unknown
Route ORAL
Formulation TABLET
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is chlorphenesin carbamate?
chlorphenesin carbamate (MAOLATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for chlorphenesin carbamate?
MAOLATE is a marketed brand name for chlorphenesin carbamate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlorphenesin carbamate?
chlorphenesin carbamate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.